Terra Innovatum Global N.V. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Terra Innovatum Global N.V. (Nasdaq: NKLR) on December 17, 2025. The registrant is incorporated in The Netherlands with principal executive offices in Lucca, Italy. The filing primarily addresses Item 5.02 regarding the appointment of certain officers and the approval of compensatory arrangements.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation agreements and specific bonus payments approved by the Remuneration Committee.
Material Changes and Compensation Details
On December 17, 2025, the Remuneration Committee approved Directorship Agreements for three executive directors. The agreements outline fixed annual compensation for fiscal years 2025 and 2026:
- Alessandro Petruzzi (CEO): EUR 500,000 for 2025 (pro rata); EUR 558,000 for 2026.
- Massimo Morichi (Chief Strategy Officer): EUR 400,000 for 2025 (pro rata); EUR 450,000 for 2026.
- Cesare Frepoli (Chief Operating Officer): EUR 450,000 for 2025 (pro rata); EUR 5,000,000 for 2026.
Additionally, on December 22, 2025, the Committee approved bonus payments to officers of the wholly-owned subsidiary, Terra Innovatum s.r.l., in recognition of the successful business combination and Nasdaq listing. Approved bonuses include:
- Alessandro Petruzzi: EUR 130,374.00
- Cesare Frepoli: EUR 116,832.00
- Massimo Morichi: EUR 105,144.00
- Marco Cherubini: EUR 16,832.00
- Guillaume Moyen: $100,002.00
- Morichi Atelier LLC (Giordano Morichi): $131,400.00
Further additional payments were approved for Mr. Petruzzi, Mr. Cherubini, and Mr. Frepoli ranging from EUR 47,700 to EUR 75,000 per individual, with some entries appearing duplicated in the source text.
Outlook, Risks, and Contractual Terms
The Directorship Agreements have a one-year term ending after the 2026 annual general meeting, subject to annual renewal. Key contractual provisions include:
- Change in Control: Termination without just cause or resignation for just cause in connection with a change in control triggers a lump sum payment equal to 18 months of fixed compensation plus the target bonus (calculated at 100% achievement), pro-rated accrued bonus, 18 months of healthcare coverage, and outplacement benefits.
- Equity: Awards under equity plans may continue to vest or accelerate depending on underlying award terms.
- Restrictions: Agreements include non-disparagement and non-solicitation clauses for 12 months post-termination.
- Intellectual Property: The Registrant retains exclusive ownership of IP originated by the Managers during their service.
Investor Verification Checklist
- Verify the accuracy of the EUR 5,000,000 fixed compensation figure for Cesare Frepoli for 2026, as this is significantly higher than the other executives and may be a typographical error in the source text.
- Review the full text of Exhibits 10.1, 10.2, and 10.3 to confirm specific performance criteria for the variable bonus components.
- Confirm the total aggregate cash outflow for the subsidiary bonus payments and additional payments, noting the potential duplication of entries for Mr. Petruzzi, Mr. Cherubini, and Mr. Frepoli in the source text.
- Assess the impact of the 18-month severance package on future liquidity in the event of a change in control.